Nuclear power is coming back — and that could be a win for older workers
Read more at MarketWatch
Topics
-
Google Backs New Nuclear Plants to Power AI
Tech - The Wall Street Journal - October 14 -
Your parents’ Medicare decisions could come back to haunt you
Business - MarketWatch - October 19 -
Winning the US election could come down to this small Pennsylvania county
World - Financial Times - 3 days ago -
Big Tech’s dash for nuclear power
Business - Financial Times - October 20 -
Can Cam Rising return to Utah in 2025? How Utes star QB could come back with eighth year of eligibility
Sports - CBS Sports - October 14 -
Can Boeing come back?
Business - Financial Times - 6 days ago -
Carville to MSNBC host: 'When the paddy wagon comes, you and I are going to be in the back of it' if Trump wins
Politics - The Hill - October 22 -
Google turns to nuclear to power AI data centres
Top stories - BBC News - October 15 -
Amazon, Google and Microsoft Are Investing in Nuclear Power
Business - The New York Times - October 16
More from MarketWatch
-
Palantir’s stock surges as AI drives a further acceleration in growth
Business - MarketWatch - 2 hours ago -
Marqeta’s stock may shed a third of its value as these factors spur weak outlook
Business - MarketWatch - 2 hours ago -
Hims & Hers shares rally on results, but execs say GLP-1 drug shortage ‘is not abating’
Business - MarketWatch - 2 hours ago -
Dollar Tree’s CEO steps down. An analyst says the move comes at a ‘difficult time.’
Business - MarketWatch - 2 hours ago -
Super Micro needs a new CEO before its AI advantage erodes
Business - MarketWatch - 3 hours ago
Latest in Business
-
Chinese equities outperform ahead of US election
Business - Financial Times - 1 hour ago -
Trump's tariffs could trigger 'dramatic' price spikes on clothes, furniture, warns retail group
Business - CNBC - 2 hours ago -
Palantir’s stock surges as AI drives a further acceleration in growth
Business - MarketWatch - 2 hours ago -
Marqeta’s stock may shed a third of its value as these factors spur weak outlook
Business - MarketWatch - 2 hours ago -
Hims & Hers shares rally on results, but execs say GLP-1 drug shortage ‘is not abating’
Business - MarketWatch - 2 hours ago